Considering that GLP-1 infusion increases postprandial satiety in normal weight 7 as well as obese humans, 14 a delay in the postprandial GLP-1 response might affect food intake regulation and in particular impact inter-meal snacking that has been shown to be augmented after sleep loss
A third, recent study in JAMA Network Open , from August of 2025, analyzed data from 159,000 people with type 2 diabetes who took semaglutide or tirzepatide (Mounjaro, Zepbound)
Oct 2009;13(5):363-77
Each study will also include a one-year extension allowing participants the opportunity to continue receiving treatment following completion of the primary dosing period, including patients receiving placebo during the initial portion of the trial
Buy It Now Description Certificate of Analysis Additional information Description Description Ipamorelin is a selective GHS peptide widely studied for its ability to stimulate the ghrelin receptor (GHS-R1a) activation
What's it actually like to take a GLP-1